Jennifer Kim
Stock Analyst at Cantor Fitzgerald
(0.53)
# 2407
Out of 5,331 analysts
47
Total ratings
37.50%
Success rate
1.89%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BLTE Belite Bio | Reiterates: Overweight | n/a | n/a | n/a | 4 | Mar 18, 2025 | |
INSM Insmed | Reiterates: Overweight | n/a | n/a | n/a | 8 | Feb 20, 2025 | |
FBIO Fortress Biotech | Reiterates: Overweight | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
EYPT EyePoint Pharmaceuti... | Reiterates: Overweight | n/a | n/a | n/a | 6 | Jun 20, 2024 | |
ALLK Allakos | Reiterates: Neutral | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 | n/a | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 0.77 | 159.74% | 2 | Aug 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 14 | 4.12 | 239.81% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 33 | 3.33 | 890.99% | 2 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 5 | 1.99 | 126.13% | 2 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | n/a | n/a | 2 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 220 100 | 1.31 | 7533.59% | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 56 | n/a | n/a | 2 | Mar 17, 2022 |